EPZM

Epizyme, Inc. News Headlines

$22.57
*  
0.78
 negative 
3.34%
Get EPZM Alerts
*Delayed - data as of Apr. 24, 2014 12:51 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    EPZM Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Epizyme Up on Milestone Payment from Glaxo - Analyst Blog
4/23/2014 7:10:01 PM - Zacks.com

Epizyme Posts Q4 Profit
2/27/2014 6:19:00 PM - RTT News

Epizyme To Present At Leerink Global Healthcare Conference;Webcast At 2:15PM
2/12/2014 1:15:00 PM - RTT News

Epizyme To Present At BIO CEO & Investor Conference; Webcast At 3:30 PM ET
2/11/2014 2:30:00 PM - RTT News

Epizyme Prices Stock Offering
2/5/2014 12:17:00 PM - RTT News

Biotech Boomlet Set To Smash IPO Record For Two-Week Period
2/2/2014 5:42:00 AM - Seeking Alpha

Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
1/28/2014 9:31:00 AM - Seeking Alpha

Is The Healthcare Sector Pulling Back Or Crashing?
1/28/2014 5:40:00 AM - Seeking Alpha

Epizyme Up on Milestone Payments - Analyst Blog
1/8/2014 1:10:01 PM - Zacks.com

Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook
1/8/2014 10:17:00 AM - Investopedia

Cramer's Mad Money - My New Year's Resolution For Investing (1/7/14)
1/8/2014 5:40:00 AM - Seeking Alpha

Epizyme: Exciting Science, Exciting Investment Opportunity
12/19/2013 12:41:00 PM - Seeking Alpha

Epizyme: The Promise Of Personalized Cancer Therapy
9/15/2013 8:21:00 PM - Seeking Alpha

Scientific Conferences Create Buzz And Move Biotech Stocks: Michael King
9/6/2013 11:24:00 AM - Seeking Alpha

Epizyme Wins Orphan Drug Status - Analyst Blog
8/22/2013 11:30:01 AM - Zacks.com

New Cancer Targets And Big Partnerships May Be Driving Huge Epizyme Valuation
8/21/2013 12:44:00 PM - Seeking Alpha

Cramer's Lightning Round - How Much Do I Like Kroger? (8/20/13)
8/21/2013 6:31:00 AM - Seeking Alpha

Epizyme Gets Orphan Drug Designation On Leukemia Drug
8/20/2013 1:43:00 PM - Seeking Alpha

Epizyme Continues To Shine
7/16/2013 1:52:00 PM - Seeking Alpha

Cramer's Mad Money - 19 Things To Watch In The Week Ahead (7/12/13)
7/14/2013 5:13:00 AM - Seeking Alpha

In Insider Trading, Biopharma Companies Synta Pharmaceuticals and Epizyme See Purchases
6/7/2013 12:35:00 PM - Minyanville

Epizyme Up Big After IPO - Impressive Pipeline
6/4/2013 2:52:00 PM - Seeking Alpha

Epizyme - Investors Are Wildly Enthusiastic About Future Prospects Of This Recent IPO
6/4/2013 6:14:00 AM - Seeking Alpha

Company News for June 3, 2013 - Corporate Summary
6/3/2013 10:33:14 AM - Zacks.com

4 US IPOs planned for the week of Jun 3
6/3/2013 8:00:04 AM - Renaissance Capital